New Genetic Disorder Identified In 19-month-old Baby Girl in Michigan

A genetic disorder which was previously found in animals has now affected a human being. This disorder was caused by mutations in a ornithine decarboxylase 1 (ODC1) gene.

A genetic disorder which was previously found in animals has now affected a 19-month-old Girl in Michigan.

Researchers from the Michigan State University found that the disorder is caused by mutations in a gene known as ornithine //decarboxylase 1 (ODC1).

Gene Therapy Can Increase Life Span of Genetic Disorders
Adrenoleukodystrophy, an X-linked genetic disease that usually affects boys can be treated with stem cells after chemotherapy.

TOP INSIGHT

The genetic disorder has been found to be caused by a mutation in a gene called as ornithine decarboxylase 1 (ODC1).

It is defined by a number of clinical features including large birth weight, enlarged head size, hair loss, reduced muscle strength, skin lesions, hearing loss and developmental delays.

"This remarkable case represents the first human example of a disorder that was described by researchers in a transgenic mouse model more than 20 years ago," said Andre Bachmann, Professor at the varsity.

However, the disorder is, as of yet, unnamed, and its long-term effects, which include impacts on the neurological system, are not completely known.

New 'checkpoint' Model to Develop Drugs for Genetic Disorders
New model can be used to develop screening tests for both genes and chemical compounds.

The disorder was first identified on an 11-month-old baby girl in Michigan.

In the study, published in the American Journal of Medical Genetics Part A, blood samples for testing were drawn at age 19 months and 32 months.

Lipids Play Important Role in Heart Diseases, Hepatitis and Genetic Disorders
Study investigates the role of circulating lipids like cholesterol in metabolic diseases.

Two developmentally normal, age/gender-matched patients that were being sedated for outpatient same-day procedures served as controls.

Red blood cells obtained from the patient showed elevated ODC protein and polyamine levels compared to healthy controls.

Whole Genome Sequencing Allows Doctors to Rapidly Diagnose Children With Genetic Disorders
A new report reveals that investigators at Children's Mercy Hospitals and Clinics in Kansas City have used the whole genome information to arrive at a diagnosis in critically ill infants.

"The ODC1 gene plays an important role in a number of physiological and cell developmental processes including embryo and organ development," said Caleb Bupp, a medical geneticist at Spectrum Health -- a US-based healthcare company.

The study also showed that the ODC inhibitor DFMO -- a water-soluble -- and US Food Drug Administration (FDA)-approved drug may serve as a disease-modifying drug, and an early therapeutic trial in a new diagnosis may prevent some of the clinical symptoms.

DFMO has been used for many years in the treatment of trypanosomiasis -- a tropical disease transmitted by biting insects and more recently entered clinical trials for pediatric neuroblastoma and colon cancer.

In mice, DFMO prevented hair loss and also partially restored hair growth and is considered a well-tolerated drug.

The original ODC1 mouse model was developed by Thomas G. O'Brien in 1995 at the Lankenau Medical Research Centre in Pennsylvania.

Source-Eurekalert